Cas 1236861-83-8,(S)-3-(Pyrimidin-2-yloxy)-pyrrolidine-1-carboxylic acid tert-butyl ester

1236861-83-8

Post Buying Request

Basic information

Product Name: (S)-3-(Pyrimidin-2-yloxy)-pyrrolidine-1-carboxylic acid tert-butyl ester
Synonyms: (S)-3-(Pyrimidin-2-yloxy)-pyrrolidine-1-carboxylic acid tert-butyl ester
CAS NO:1236861-83-8
Molecular Formula: C13H19N3O3
Molecular Weight: 265.30826
EINECS: N/A
Product Categories: N/A
Mol File: 1236861-83-8.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: /
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (S)-3-(Pyrimidin-2-yloxy)-pyrrolidine-1-carboxylic acid tert-butyl ester(CAS DataBase Reference)
NIST Chemistry Reference: (S)-3-(Pyrimidin-2-yloxy)-pyrrolidine-1-carboxylic acid tert-butyl ester(1236861-83-8)
EPA Substance Registry System: (S)-3-(Pyrimidin-2-yloxy)-pyrrolidine-1-carboxylic acid tert-butyl ester(1236861-83-8)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1236861-83-8(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1236861-83-8 Suppliers

Recommended suppliersmore

1236861-83-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1236861-83-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,3,6,8,6 and 1 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1236861-83:
(9*1)+(8*2)+(7*3)+(6*6)+(5*8)+(4*6)+(3*1)+(2*8)+(1*3)=168
168 % 10 = 8
So 1236861-83-8 is a valid CAS Registry Number.

1236861-83-8Upstream product

1236861-83-8Downstream Products

1236861-83-8Relevant articles and documents

AMINO-HETEROCYCLIC COMPOUNDS

-

Page/Page column 32-33, (2010/08/07)

The invention provides PDE9-inhibiting compounds of Formula (I), and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, A, and n are as defined herein. Pharmaceutical compositions containing the compounds of Formula I, and uses thereof in treating neurodegenerative and cognitive disorders, such as Alzheimer's disease and schizophrenia, are also provided.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1236861-83-8